Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Macaluso

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.
Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.
International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.
Journal of Affective Disorders|July 9, 2025
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders With Treatment Resistant Depression (ASCERTAIN-TRD): Effect of Aripiprazole or Repetitive Transcranial Magnetic Stimulation Augmentation Versus Switching to the Antidepressant Venlafaxine on Quality of LifeClotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
Brain Stimulation|December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trialCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
The International Journal of Neuropsychopharmacology|January 13, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial reportCharles R Conway, Augustus John Rush, Scott T Aaronson, et al.
JAMA Network Open|February 25, 2026
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task ForceJoseph F Goldberg, Roger S McIntyre, Holly A Swartz, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.
Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.
International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.
Journal of Affective Disorders|July 9, 2025
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders With Treatment Resistant Depression (ASCERTAIN-TRD): Effect of Aripiprazole or Repetitive Transcranial Magnetic Stimulation Augmentation Versus Switching to the Antidepressant Venlafaxine on Quality of LifeClotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
Brain Stimulation|December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trialCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
The International Journal of Neuropsychopharmacology|January 13, 2026
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial reportCharles R Conway, Augustus John Rush, Scott T Aaronson, et al.
JAMA Network Open|February 25, 2026
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task ForceJoseph F Goldberg, Roger S McIntyre, Holly A Swartz, et al.
Pageof 7